• Print

Interoperability Need: Reporting Antimicrobial Use and Resistance Information to Public Health Agencies


Interoperability Need: Reporting Antimicrobial Use and Resistance Information to Public Health Agencies

Interoperability Need: Reporting Antimicrobial Use and Resistance Information to Public Health Agencies

Type

Standard/Implementation Specification

Standards Process Maturity

Implementation Maturity

Adoption Level

Federally Required

Cost

Test Tool Availability

Standard

HL7 Clinical Document Architecture (CDA®), Release 2.0, Final Edition

Final

Production

rating 5

No

Free

No

Implementation Specification

HL7 Implementation Guide for CDA® Release 2 – Level 3: Healthcare Associated Infection Reports, Release 1, U.S. Realm.

Final

Production

rating 1

Yes

Free

No

Emerging Implementation Specification

HL7 Implementation Guide for CDA Release 2 – Level 3: NHSN Healthcare Associated Infection (HAI) Reports Release 2, DSTU Release 2.1

Balloted Draft

Pilot

rating 1

No

Free

No

Limitations, Dependencies, and Preconditions for Consideration:

Applicable Security Patterns for Consideration:

  • This is a national reporting system to CDC. Stakeholders should refer to implementation guide for additional details and contract information for enrolling in the program.
  • See CDA projects in the Interoperability Proving Ground.
  • Secure Communication – create a secure channel for client-to- serve and server-to-server communication.
  • Secure Message Router – securely route and enforce policy on inbound and outbound messages without interruption of delivery.
  • Authentication Enforcer – centralized authentication processes.
  • Authorization Enforcer – specified policies access control.
  • Credential Tokenizer – encapsulate credentials as a security token for reuse  (e.g., – SAML, Kerberos).
  • User Role – identifies the role asserted by the individual initiating the transaction.
  • Purpose of Use - Identifies the purpose for the transaction.
No comments have been posted yet.